Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Head and Neck Squamous Cell Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05732662
What this trial is testing

SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC

Who this might be right for
Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou 25
Not applicableLooking for participantsNCT07448727
What this trial is testing

Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT

Who this might be right for
Head & Neck CancerHead & Neck Squamous Cell Carcinoma
University of Rome Tor Vergata 25
Testing effectiveness (Phase 2)Looking for participantsNCT06753747
What this trial is testing

A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophagus Cancer
West China Hospital 45
Testing effectiveness (Phase 2)Study completedNCT04144517
What this trial is testing

ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Mural Oncology, Inc 14
Testing effectiveness (Phase 2)Ended earlyNCT00062387
What this trial is testing

Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT02123511
What this trial is testing

Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

Who this might be right for
MucositisOral ComplicationsRecurrent Adenoid Cystic Carcinoma of the Oral Cavity+80 more
Mayo Clinic 34
Early research (Phase 1)Looking for participantsNCT04754321
What this trial is testing

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Who this might be right for
Head and Neck Carcinoma of Unknown PrimaryLocally Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+3 more
Ohio State University Comprehensive Cancer Center 45
Not applicableLooking for participantsNCT06476067
What this trial is testing

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal CancerRecurrenceDNA Methylation
City of Hope Medical Center 150
Early research (Phase 1)Ended earlyNCT03525392
What this trial is testing

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerGastric Cancer+5 more
Ipsen 14
Testing effectiveness (Phase 2)UnknownNCT05027204
What this trial is testing

Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 94
Testing effectiveness (Phase 2)Study completedNCT01816984
What this trial is testing

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+33 more
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT02319044
What this trial is testing

Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
AstraZeneca 267
Large-scale testing (Phase 3)WithdrawnNCT01545687
What this trial is testing

CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy

Who this might be right for
Head and Neck CancerOral Complications of Radiation TherapyPain+1 more
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00021333
What this trial is testing

Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer

Who this might be right for
Head and Neck CancerLung Cancer
Fox Chase Cancer Center 29
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)UnknownNCT00022217
What this trial is testing

Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Matrix Pharmaceutical
Large-scale testing (Phase 3)Study completedNCT00401323
What this trial is testing

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis
Sanofi 568
Large-scale testing (Phase 3)Study completedNCT02369874
What this trial is testing

Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer

Who this might be right for
Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN
AstraZeneca 736
Testing effectiveness (Phase 2)Looking for participantsNCT07136545
What this trial is testing

A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)

Who this might be right for
HNSCC
Taipei Veterans General Hospital, Taiwan 50
Testing effectiveness (Phase 2)Study completedNCT00006245
What this trial is testing

Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Next Page